home
|
site map
|
Terms & conditions
|
español
AIM
NEWS
Neuron News
Neuron on the media
LINKS
Associations and Fundations
Institutions
EVENTS
SOCIAL RESPONSIBILITY
CONTACT
SHAREHOLDERS AND INVESTORS
05/NOV/13
OECD validates safety studies of compounds and extracts in Zebrafish offered by Neuron BioServices
10/OCT/13
A study from the Johns Hopkins University reinforces the working hypothesis of Neuron BioPharma
30/SEP/13
Neol, the Spanish company from the Neuron Bio group signs an agreement with the Colombian company Colbiocel, which will allow the promotion of production projects for new generation biofuels
03/SEP/13
A study of 58,000 patients supports the Neuron BioPharma working line
31/JUL/13
José Antonio Griñán awards the prize for Premio Andalucía de Investigación research to Neuron Bio
29/JUL/13
Neuron BioServices accredited as an authorized organism for the evaluation of animal experimentation projects
03/JUL/13
Neuron BioPharma presents to the pharmaceutical industry the latest advances in the NST0037 compound, a potential treatment for Alzheimer’s disease
01/JUL/13
Success for the second Neuron Bio blood donation day
26/JUN/13
Neuron BioServices offers the analysis of ingredients and pharmaceutical compounds for the development of the central nervous system
12/JUN/13
Neuron Bio discovers two new molecules which enter the brain more effectively and avoid neuronal death
05/JUN/13
Is our compound safe for the eyes?
03/JUN/13
Exclusive zebrafish model for studying epilepsy and searching for new antiepileptic drugs
28/MAY/13
An independent study valuates Neuron Bio three times more than its stock market quotation
30/APR/13
Neuron Bio attends the most important biotechnological trade fair in the world
26/APR/13
Neuron BioServices exposes research with zebrafish to the Fundación Moderna de Navarra
10/APR/13
The Spanish Patents and Trademarks Office (OEPM) grants Neuron Bio the patent for the neuroprotective compound NST0060
09/APR/13
Fernando Valdivieso shares his innovation experience of Neuron Bio in the Technological Corporation of Andalusia (CTA) forum
02/APR/13
Neuron BioServices includes in its services techniques to measure the anti-inflammatory/immunological capacity of compounds
20/MAR/13
Press Release
20 March 2013
Neuron Bio expands with new facilities in the Science Park in Madrid
15/MAR/13
Neuron Bio, present at the International Conference on Alzheimer's & Parkinson's Diseases
13/MAR/13
Neuron BioServices conforms to the new regulations concerning safety studies with the zebrafish model
11/MAR/13
Neuron BioServices develops a study for detecting side effects of new compounds in the ear
22/FEB/13
Neuron Bio shares its experience in collaboration with public research centers in Transfiere 2013
15/FEB/13
Neuron Bio shares its patents experience in Transfiere 2013
18/JAN/13
Neuron BioPharma attends the JP Morgan Investors Healthcare Conference
Neuron Bio |
Neuron BioPharma
|
Neuron BioServices